BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9781154)

  • 1. [Late treatment related complications of Hodgkin's disease].
    Henry-Amar M; Gisselbrecht C
    Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late complications of Hodgkin's disease management.
    Young RC; Bookman MA; Longo DL
    J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid second cancers following Hodgkin's disease.
    Tucker MA
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):389-400. PubMed ID: 8468272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term toxicity of curative lymphoma therapy].
    Gassmann W; Slanina J
    Internist (Berl); 1993 Feb; 34(2):161-9. PubMed ID: 8454430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare, late complications in a patient with Hodgkin's disease.
    Illés A; Gergely L; Miltényi Z; Keresztes K; Olvasztó S; Redl P; Dankó K
    Haematologia (Budap); 2002; 32(4):509-18. PubMed ID: 12803127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 19. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
    Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.